Differentiation syndrome in acute promyelocytic leukemia: pathogenesis and risk factors

Differentiation syndrome is a treatment complication which can occur in acute promyelocytic leukemia (APL) patients treated with all-trans retinoic acid (ATRA) or arsenic trioxide (ATO), which is characterized by enhanced leukocyte transmigration. Several cellular and molecular mechanisms participate in differentiation syndrome development. This review discusses the changes in expression of adhesion molecules induced during ATRA and ATO treatments and their possible implications in the pathogenesis of this potentially fatal complication.

Saved in:
Bibliographic Details
Main Authors: Rego,Eduardo M., Santana-Lemos,Bárbara A. A., Tamarozzi,Mirela B.
Format: Digital revista
Language:English
Published: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular 2008
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842008000800009
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1516-84842008000800009
record_format ojs
spelling oai:scielo:S1516-848420080008000092008-12-09Differentiation syndrome in acute promyelocytic leukemia: pathogenesis and risk factorsRego,Eduardo M.Santana-Lemos,Bárbara A. A.Tamarozzi,Mirela B. Acute promyelocytic leukemia adhesion molecules retinoids arsenic trioxide Differentiation syndrome is a treatment complication which can occur in acute promyelocytic leukemia (APL) patients treated with all-trans retinoic acid (ATRA) or arsenic trioxide (ATO), which is characterized by enhanced leukocyte transmigration. Several cellular and molecular mechanisms participate in differentiation syndrome development. This review discusses the changes in expression of adhesion molecules induced during ATRA and ATO treatments and their possible implications in the pathogenesis of this potentially fatal complication.info:eu-repo/semantics/openAccessAssociação Brasileira de Hematologia e Hemoterapia e Terapia CelularRevista Brasileira de Hematologia e Hemoterapia v.30 suppl.2 20082008-06-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842008000800009en10.1590/S1516-84842008000800009
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Rego,Eduardo M.
Santana-Lemos,Bárbara A. A.
Tamarozzi,Mirela B.
spellingShingle Rego,Eduardo M.
Santana-Lemos,Bárbara A. A.
Tamarozzi,Mirela B.
Differentiation syndrome in acute promyelocytic leukemia: pathogenesis and risk factors
author_facet Rego,Eduardo M.
Santana-Lemos,Bárbara A. A.
Tamarozzi,Mirela B.
author_sort Rego,Eduardo M.
title Differentiation syndrome in acute promyelocytic leukemia: pathogenesis and risk factors
title_short Differentiation syndrome in acute promyelocytic leukemia: pathogenesis and risk factors
title_full Differentiation syndrome in acute promyelocytic leukemia: pathogenesis and risk factors
title_fullStr Differentiation syndrome in acute promyelocytic leukemia: pathogenesis and risk factors
title_full_unstemmed Differentiation syndrome in acute promyelocytic leukemia: pathogenesis and risk factors
title_sort differentiation syndrome in acute promyelocytic leukemia: pathogenesis and risk factors
description Differentiation syndrome is a treatment complication which can occur in acute promyelocytic leukemia (APL) patients treated with all-trans retinoic acid (ATRA) or arsenic trioxide (ATO), which is characterized by enhanced leukocyte transmigration. Several cellular and molecular mechanisms participate in differentiation syndrome development. This review discusses the changes in expression of adhesion molecules induced during ATRA and ATO treatments and their possible implications in the pathogenesis of this potentially fatal complication.
publisher Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular
publishDate 2008
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842008000800009
work_keys_str_mv AT regoeduardom differentiationsyndromeinacutepromyelocyticleukemiapathogenesisandriskfactors
AT santanalemosbarbaraaa differentiationsyndromeinacutepromyelocyticleukemiapathogenesisandriskfactors
AT tamarozzimirelab differentiationsyndromeinacutepromyelocyticleukemiapathogenesisandriskfactors
_version_ 1756423451095072768